Publication:
Withdrawal of low-dose prednisone in inactive SLE patients: Is there another alternative?

dc.contributor.authorSabio, José Mario
dc.date.accessioned2023-05-03T13:30:02Z
dc.date.available2023-05-03T13:30:02Z
dc.date.issued2020-04-27
dc.identifier.doi10.1136/annrheumdis-2020-217575
dc.identifier.essn1468-2060
dc.identifier.pmid32340975
dc.identifier.unpaywallURLhttps://ard.bmj.com/content/annrheumdis/early/2020/04/26/annrheumdis-2020-217575.full.pdf
dc.identifier.urihttp://hdl.handle.net/10668/20047
dc.issue.number4
dc.journal.titleAnnals of the rheumatic diseases
dc.journal.titleabbreviationAnn Rheum Dis
dc.language.isoen
dc.organizationHospital Universitario Virgen de las Nieves
dc.page.numbere57
dc.pubmedtypeLetter
dc.pubmedtypeComment
dc.rights.accessRightsopen access
dc.subjectautoimmune diseases
dc.subjectglucocorticoids
dc.subjectimmune system diseases
dc.subject.meshGlucocorticoids
dc.subject.meshHumans
dc.subject.meshLupus Erythematosus, Systemic
dc.subject.meshPrednisone
dc.subject.meshSeverity of Illness Index
dc.titleWithdrawal of low-dose prednisone in inactive SLE patients: Is there another alternative?
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number81
dspace.entity.typePublication

Files